← Leaderboards
Don Gustavson
Peritec Biosciences
$1,024,966
Attributed
$1,024,966
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $417.3K · FY2012–14$500K$375K$250K$125K$0
'12
'13
'14
Funding mix
By agency
NIH$1,024,966 · 1
By mechanism
R44$1,024,966 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAgingAmericanAnastomosis - ActionAnimal ModelAnimalsAnimal TestingAreaBiocompatible MaterialsBiologicalBloodBlood FlowBlood VesselsCessation Of LifeCharacteristicsChronicChronic Kidney FailureClinical ResearchCoagulation ProcessCommercializationComputer-Aided DesignComputer AssistedCorrosionAcute
Grant awards (3)
Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure$417,257
R44 · FY2014 · DK · contact PI
Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure$415,759
R44 · FY2013 · DK · contact PI
Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure$191,950
R44 · FY2012 · DK · contact PI